Karen T Liby

9PUBLICATIONS
38CO-AUTHORS
Radiation therapyMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 28, 2026
RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to Bexarotene.

Afrin Sultana Chowdhury, Lyndsey A Reich, Karen T Liby

|Dec 30, 2025
Synthetic Oleanane Triterpenoids Reduce Tumor Growth and Promote an Anti-Tumor Immune Response Independent of Cancer KEAP1 Mutational Status.

Christopher J Occhiuto, Jessica A Moerland, Karen T Liby

|Jun 26, 2025
The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.

Pei-Yu Hung, Jessica A Moerland, Ana S Leal

|Sep 28, 2024
The BRD4 Inhibitor I-BET-762 Reduces HO-1 Expression in Macrophages and the Pancreas of Mice.

Ana S Leal, Karen T Liby

|Jun 27, 2024
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer.

Jessica A Moerland, Karen T Liby

|Mar 28, 2024
KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype.

Christopher J Occhiuto, Karen T Liby

Pageof 2

Frequent Collaborators

3 joint publications

Ana S Leal

3 joint publications

Jessica A Moerland

3 joint publications

Christopher J Occhiuto

1 joint publications

Lyndsey A Reich